2019 American Transplant Congress
Incidence of Autoresuscitation in Donation after Cardiac Death Donors
*Purpose: Donation after cardiac death (DCD) donors are subject to an observation period after asystole to monitor for cardiopulmonary autoresuscitation (AR). Periods vary between and…2019 American Transplant Congress
Tacrolimus Pharmacokinetics in Young, Middle Age and Older Renal Transplant Recipients- Impact of CYP3A5*3*6*7 Metabolic Composite
*Purpose: In spite of increased renal transplantation in patients over 60 years and the need for age-adjusted tacrolimus maintenance immunosuppression, limited pharmacokinetic comparisons between young,…2019 American Transplant Congress
Impact of Functional Delayed Graft Function in the Modern Era of Kidney Transplantation
Renal Transplant Unit, Hospital Clínic, Barcelona, Spain
*Purpose: the classical definition of Delayed Graft Function (DGF) (i.e. need of dialysis during the first week after kidney transplant) depends on the physician attitude…2019 American Transplant Congress
Predicted Indirectly Recognizable H L A Epitopes Are Associated with T-cell Mediated Rejection among Kidney Transplant Recipients with Preformed and De Novo Donor-Reactive T-cells
*Purpose: Very recently Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) have been suggested to demonstrate early and late effects on kidney allograft outcomes. The association between…2019 American Transplant Congress
Access To The Kidney Transplant Waitlist For Patients With Hiv And End-stage Renal Disease
*Purpose: Patients with HIV and end-stage renal disease (ESRD) experience higher mortality on dialysis than those without HIV. These HIV+ dialysis patients may face barriers…2019 American Transplant Congress
Quantifying Differential Infection Risks in HLA- and/or ABO- Incompatible Kidney Transplant Recipients
1Johns Hopkins, Baltimore, MD, 2New York University, New York, NY
*Purpose: Desensitization has enabled kidney transplantation across HLA-and/or ABO barriers and has conferred survival benefit to patients who lack compatible living donors (CLDKT). However, due…2019 American Transplant Congress
Incorporating Tangible Benefits into the Risk-Benefit Analysis of Living Organ Donation Decisions
1University of Maryland, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD
*Purpose: The risk-benefit framework currently used in living organ donation presumes all benefit is afforded to the recipient, whereas the donor only assumes risks. However,…2019 American Transplant Congress
Tissue Resident Memory T Cells in Murine Renal Transplantation
Starzl Transplantation Institute, Pittsburgh, PA
*Purpose: The newly identified tissue resident subset of memory T cells (TRM) provides immune surveillance in the tissue and first response against infections. They are…2019 American Transplant Congress
Multicenter Cohort Study of Frailty and Access to Kidney Transplantation
1JHU, Baltimore, MD, 2MIchigan, Ann Arbor, MI, 3Methodist, San Antonio, TX
*Purpose: Frailty, a syndrome distinct from comorbidity and disability, is clinically manifested as a decreased resistance to stressors and is present in up to 35%…2019 American Transplant Congress
Ten Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients
1Northwestern U, Chicago, IL, 2Duke U, Durham, NC, 3U Louisville, Louisville, KY
*Purpose: 37 subjects have been transplanted in a phase 2 protocol to induce tolerance in recipients of living donor renal allografts (KTx) based upon tolerogenic…
- « Previous Page
- 1
- …
- 135
- 136
- 137
- 138
- 139
- …
- 214
- Next Page »